Last reviewed · How we verify

bupivacaine and epinephrine

Mayo Clinic · FDA-approved active Small molecule Quality 5/100

bupivacaine and epinephrine is a Small molecule drug developed by Mayo Clinic. It is currently FDA-approved. Also known as: Sensorcaine-MPF with Epinephrine 1:200,000.

At a glance

Generic namebupivacaine and epinephrine
Also known asSensorcaine-MPF with Epinephrine 1:200,000
SponsorMayo Clinic
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about bupivacaine and epinephrine

What is bupivacaine and epinephrine?

bupivacaine and epinephrine is a Small molecule drug developed by Mayo Clinic.

Who makes bupivacaine and epinephrine?

bupivacaine and epinephrine is developed and marketed by Mayo Clinic (see full Mayo Clinic pipeline at /company/mayo-clinic).

Is bupivacaine and epinephrine also known as anything else?

bupivacaine and epinephrine is also known as Sensorcaine-MPF with Epinephrine 1:200,000.

What development phase is bupivacaine and epinephrine in?

bupivacaine and epinephrine is FDA-approved (marketed).

Related